The Street is leaning firmly positive on SRE ahead of Thursday's Q1 results — but the stock is trading nearly 10% below where most analysts think it should be.
The analyst picture has tilted constructive over the past few weeks. Morgan Stanley maintained its Overweight rating on April 21 while trimming its target by just $1 to $104. That same day, Truist initiated coverage with a Buy and a $108 target. Barclays had already raised its target from $95 to $105 on April 15, keeping its Overweight intact. Across the group, the consensus mean target is $104.29, against a current price of $94.38 — implying roughly 10% upside. The factor score for analyst recommendation divergence ranks in the 97th percentile, a signal that the Street is more aligned toward Buy than for the vast majority of comparable stocks.
Bulls point to the scale of Sempra's infrastructure holdings — 80% ownership of Oncor in Texas and a 25% stake in Sempra Infrastructure — as the core growth engine, with regulatory clarity on California utility standards potentially unlocking further terminal value. The bear case centres on execution risk in the LNG development pipeline, wildfire liability exposure across California operations, and the drag from higher net interest costs at the parent level. EV/EBITDA has eased roughly 3% over the past 30 days to around 16.8x, a mild de-rating that the bulls may view as an entry opportunity while bears see it as the market adjusting to those risks.
Short sellers have little conviction here. Short interest is just 1.37% of the free float — a level that removes any meaningful squeeze dynamic from the earnings setup. More notably, short interest fell 15.6% over the past week, unwinding a mid-April buildup that briefly pushed shares short above 10.7 million. Borrow conditions confirm the absence of pressure: the cost to borrow is minimal at 0.36% annualised, and availability is ample. Options positioning tells the same relaxed story. The put/call ratio is running at 0.30, in line with its 20-day average of 0.31 and near its 52-week low — there is almost no demand for downside protection heading into the print. Peers moved broadly in line with SRE's 2.1% weekly gain, with AEE, WEC, and D all posting comparable moves, suggesting no idiosyncratic positioning around Thursday's release.
The Q1 print will test whether LNG project progress and Oncor earnings growth are pacing ahead of the interest-cost headwinds that the bear case keeps returning to — and whether consensus's 97th-percentile bullishness is justified at a price still a full turn below the mean target.
See the live data behind this article on ORTEX.
Open SRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
